Fig. 8From: Cellular dosimetry of [177Lu]Lu-DOTA-[Tyr3]octreotate radionuclide therapy: the impact of modeling assumptions on the correlation with in vitro cytotoxicityAbsorbed dose contribution to the nucleus from unbound, membrane bound and internalized fraction of activity (in cytoplasm) through the experiment. a corresponds to 0.1 MBq/ml and b to 2.5 MBq/ml. Calculations were performed using the avarage S values of the 9 PM geometries, including the varying cross dose. The error bars indicate the SD of the absorbed doseBack to article page